Telix Pharmaceuticals Limited (ASX:TLX)

Telix Pharmaceuticals Revenue

Telix Pharmaceuticals had revenue of $390.36M USD in the half year ending June 30, 2025, with 165.59% growth. This brings the company's revenue in the last twelve months to $664.23M, up 55.35% year-over-year. In the year 2024, Telix Pharmaceuticals had annual revenue of $484.69M with 41.49% growth.

• Revenue (ttm): $664.23M
• Revenue Growth: +55.35%
• P/S Ratio: 3.70
• Revenue / Employee: $1.54M
• Employees: 431
• Market Cap: 3.75B AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	484.69M	142.12M	41.49%
Dec 31, 2023	342.57M	233.76M	214.82%
Dec 31, 2022	108.81M	103.29M	1,870.12%
Dec 31, 2021	5.52M	1.50M	37.33%
Dec 31, 2020	4.02M	1.57M	64.26%